Sopharma AD-Sofia (XBUL:SFA) EV-to-Revenue : 0.63 (As of Jun. 04, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Sopharma AD-Sofia EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Sopharma AD-Sofia's enterprise value is лв1,184 Mil. Sopharma AD-Sofia's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was лв1,875 Mil. Therefore, Sopharma AD-Sofia's EV-to-Revenue for today is 0.63.

The historical rank and industry rank for Sopharma AD-Sofia's EV-to-Revenue or its related term are showing as below:

XBUL:SFA' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.37 Med: 0.7 Max: 1.16
Current: 0.63

During the past 13 years, the highest EV-to-Revenue of Sopharma AD-Sofia was 1.16. The lowest was 0.37. And the median was 0.70.

XBUL:SFA's EV-to-Revenue is ranked worse than
53.68% of 95 companies
in the Medical Distribution industry
Industry Median: 0.6 vs XBUL:SFA: 0.63

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-06-04), Sopharma AD-Sofia's stock price is лв6.20. Sopharma AD-Sofia's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was лв13.63. Therefore, Sopharma AD-Sofia's PS Ratio for today is 0.45.

Sopharma AD-Sofia EV-to-Revenue Historical Data

The historical data trend for Sopharma AD-Sofia's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia EV-to-Revenue Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

0.63

0.54

0.52

0.48

0.60

Sopharma AD-Sofia Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															0.48	0.53	0.54	0.70	0.60

Competitive Comparison of Sopharma AD-Sofia's EV-to-Revenue

For the Medical Distribution subindustry, Sopharma AD-Sofia's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sopharma AD-Sofia's EV-to-Revenue Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma AD-Sofia's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sopharma AD-Sofia's EV-to-Revenue falls into.

Sopharma AD-Sofia EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Sopharma AD-Sofia's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1183.660	/	1875.304
	=	0.63

Sopharma AD-Sofia's current Enterprise Value is лв1,184 Mil.
Sopharma AD-Sofia's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв1,875 Mil.

Sopharma AD-Sofia (XBUL:SFA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Sopharma AD-Sofia's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	6.20	/	13.629
	=	0.45

Sopharma AD-Sofia's share price for today is лв6.20.
Sopharma AD-Sofia's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was лв13.63.

Sopharma AD-Sofia EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia (XBUL:SFA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (XBUL:SFA) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

SPH:Poland

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (XBUL:SFA) Headlines

No Headlines